KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Current Leases: 2019-2020

Historic Current Leases for TherapeuticsMD (TXMD) over the last 1 years, with Sep 2020 value amounting to $2.4 million.

  • TherapeuticsMD's Current Leases rose 93.54% to $2.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $2.4 million, marking a year-over-year increase of 93.54%. This contributed to the annual value of $1.5 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q3 2020, TherapeuticsMD's Current Leases is $2.4 million, which was up 37.11% from $1.8 million recorded in Q1 2020.
  • In the past 5 years, TherapeuticsMD's Current Leases registered a high of $2.4 million during Q3 2020, and its lowest value of $1.2 million during Q1 2019.
  • Its 2-year average for Current Leases is $1.6 million, with a median of $1.5 million in 2019.
  • Data for TherapeuticsMD's Current Leases shows a peak YoY skyrocketed of 93.54% (in 2020) over the last 5 years.
  • Quarterly analysis of 2 years shows TherapeuticsMD's Current Leases stood at $1.5 million in 2019, then soared by 93.54% to $2.4 million in 2020.
  • Its Current Leases stands at $2.4 million for Q3 2020, versus $1.8 million for Q1 2020 and $1.5 million for Q4 2019.